For ECR 2026 (European Congress of Radiology), to be held in Vienna, Austria, “Evaluating the Applicability of HL7 mCODE in European Oncology Registries: A Mapping Study with SPECTA” has been accepted as a result of joint research by CLINIAL Inc. (Shibuya-ku, Tokyo; CEO: Takaaki Mizuno) and the National Cancer Center Japan (Chuo-ku, Tokyo; hereafter “the National Cancer Center”).
Building on the knowledge gained from this joint research, CLINIAL will advance the implementation of a foundation for standardizing cancer-care information and enabling inter-institutional collaboration.